0001193125-17-286276.txt : 20171018 0001193125-17-286276.hdr.sgml : 20171018 20170915153409 ACCESSION NUMBER: 0001193125-17-286276 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810930882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 CORRESP 1 filename1.htm CORRESP

September 15, 2017

VIA EDGAR

Christine Westbrook

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Healthcare and Insurance

100 F Street, N.E.

Washington, D.C. 20549-7010

 

Re: Krystal Biotech, Inc.

Registration Statement on Form S-1

File No. 333-220085

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Krystal Biotech, Inc. (the “Company”) hereby requests acceleration of effectiveness of its registration statement on Form S-1 (File No. 333-220085), to 4:30 p.m., Eastern Time, on September 19, 2017 or as soon as practicable thereafter. By separate letter, the underwriters of the issuance of the securities being registered have joined in this request for acceleration.

The Company respectfully requests that it be notified of such effectiveness by a telephone call to John W. Campbell, our counsel at Morrison & Foerster LLP, at 415-268-7197.

 

Very truly yours,

 

Krystal Biotech, Inc.

By:   /s/ Krish S. Krishnan
Name:   Krish S. Krishnan
Title:   Chief Executive Officer